We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Graphene-Based Material Selectively Eliminates Bacteria While Sparing Human Cells

By HospiMedica International staff writers
Posted on 28 Apr 2026

Drug-resistant bacterial infections continue to complicate wound management and device-associated care, where persistent contamination raises morbidity and costs. More...

Safer, fabric‑integrated antimicrobials could support infection control without harming host tissue. Clinicians also need options that endure washing and prolonged wear in clinical and home settings. To help address this challenge, researchers have now identified how a graphene‑based material selectively eliminates bacteria while sparing human cells.

The Korea Advanced Institute of Science and Technology (KAIST; Daejeon, Korea) reports that graphene oxide, a single‑atom‑thick carbon material bearing oxygen groups, demonstrates targeted antibacterial activity while maintaining biocompatibility. The material disperses readily in water, enabling processing into fibers and coatings suitable for textiles and personal‑care products. The work involved teams from KAIST’s Department of Materials Science and Engineering and Department of Biological Sciences.

The investigators describe a “selective antibacterial action” in which graphene oxide binds to and disrupts bacterial cell membranes while leaving human cells unaffected. According to the study, the oxygen‑containing surface groups on graphene oxide recognize a phospholipid called POPG that is present in bacterial membranes but absent from human cells. This molecular recognition allows targeted membrane damage in bacteria without collateral cytotoxicity.

When produced in nanofiber form, graphene oxide halted the growth of a broad range of pathogenic bacteria, including antibiotic‑resistant “superbugs.” In animal testing, the same material accelerated wound closure without provoking inflammation, indicating local tolerability alongside antimicrobial benefit. Durability testing showed that fibers retained antibacterial performance after repeated washing, supporting potential use in garments, medical textiles, and frequently laundered protective fabrics.

Early product translation is already under way. A graphene antibacterial toothbrush developed via faculty‑led patents has surpassed 10 million units in sales, suggesting scalability of the underlying processing methods. A textile implementation, GrapheneTex, was incorporated into uniforms worn by the Taekwondo demonstration team at the 2024 Paris Olympics and is expected in functional sportswear at upcoming events, indicating feasibility for high‑use applications.

The findings were published on March 2 in Advanced Functional Materials. The authors note that this mechanistic insight could guide the design of biocompatible, wash‑stable antimicrobial textiles for wound care, hygiene products, and wearable systems in settings where antibiotic stewardship and contact safety are priorities.

"This study is an example of scientifically uncovering why graphene can selectively kill bacteria while remaining safe for the human body. By utilizing this principle, we can expand beyond safe clothing without harsh chemicals to an infinite range of applications, including wearable devices and medical textile systems," said Professor Sang Ouk Kim.

Related Links
KAIST


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Medical Examination & Procedure Light
Vega 80
Wound Irrigation Solution
Prontosan®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Illustration of the Hēlo Thrombectomy System device (Photo courtesty of Endovascular Engineering)

FDA-Cleared Thrombectomy System Removes Pulmonary Embolism Clots

Pulmonary embolism occurs when blood clots travel to the lungs and block blood flow, potentially requiring urgent endovascular intervention to prevent death. Catheter-based clot removal can be challenging,... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.